EIS-GO: Early Identification of Steroid non-response in moderate severe active Graves* Orbitopathy, a prospective study

EIS-GO: Early Identification of Steroid non-response in moderate severe active Graves* Orbitopathy, a prospective study - Improved diagnosis for GO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51784

Enrollment

Registered

2022-08-30

Start date

2022-11-01

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves' orbitopathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Active, moderate-severe GO.

Exclusion criteria

Exclusion criteria: Treatment with steroids or other immunomodulating drugs in the past 3 months. Contra-indication for intravenous methyl prednisone (IVMP).

Design outcomes

Primary

Measure	Time frame
In vitro steroid sensitivity assay and clinical response to treatment with intravenous steroids.	—

Secondary

Measure	Time frame
Secondary endpoints for clinical steroid respons (see protocol 8.1.2) Quality of Life questionnaires	—

Countries

Netherlands

Outcome results